Enveric Biosciences Inc. (ENVB)
2.83
0.03 (1.07%)
At close: Mar 03, 2025, 12:13 PM
Enveric Biosciences Cash Flow Statement
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 | FY98 | FY97 | FY96 | FY95 | FY94 |
Net Income | -17.29M | -18.47M | -48.98M | -6.86M | -6.03M | -16.9M | -11.16M | -2.78M | -1.89M | -33.64K | -161 | -24.62K | -33.38K | -39.44K | -58.54K | -143.64K | 807.28K | -352.63K | -81.52K | -157.49K | -495.45K | 18.29K | -240.11K | 382.02K | 354.79K | -5.74M | -4.71M | -25.4M | -3.2M | -1.2M |
Depreciation & Amortization | 408.03K | 435.2K | 681.61K | 120.87K | 2.27M | 2.9M | 3.22M | 1.36M | 157.94K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 37.23K | 47.43K | 58.86K | 82.9K | 105.5K | 139.13K | 85.97K | 103.56K | 126.33K | 407.24K | 130.06K | -100K | n/a |
Stock-Based Compensation | 2.15M | 2.62M | 12.6M | 1.98M | 586.5K | 1.25M | 7.08M | 1.46M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -70.9K | -481.35K | 801.87K | -636.5K | 257.67K | -2M | 238.76K | -198.43K | -190.21K | 4.22K | 2K | n/a | -4.22K | 8K | -13.16K | n/a | -5.86K | -115.04K | -293.59K | 391.39K | 10.53K | 93.66K | -265.79K | n/a | -1.12M | 1.37M | 197.55K | -323.15K | n/a | 100K |
Other Non-Cash Items | 813.88K | -9.3K | 30.51M | 1.25M | -1.41M | 4.86M | 1.06M | 528.39K | 552.62K | n/a | -28.5K | n/a | -33.38K | -39.44K | -58.54K | n/a | -515.08K | 11.72K | 1K | n/a | 12K | -100.01K | n/a | -133.76K | -1 | 1.16M | 200K | 20.9M | 100K | 100K |
Deferred Income Tax | n/a | -1.5M | -7.45M | n/a | 388.66K | 6.35M | -2.39M | -3.49M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -174.75K | -217.66K | 1.19M | -369.5K | 1.74M | -1.03M | -539.78K | 218.45K | -2.49M | -9.52K | 7.03K | -229 | 3.03K | -1.23K | -6.5K | -6.55K | 37.73K | -2.23K | -223.48K | 442.57K | 146.58K | 61.35K | -238.7K | -188.38K | -1.12M | 1.45M | 400.84K | -357.56K | -400K | 300K |
Operating Cash Flow | -14.09M | -17.15M | -11.46M | -3.89M | -2.45M | -2.57M | -2.74M | -2.7M | -3.67M | -43.16K | -21.63K | -24.85K | -30.35K | -40.67K | -65.04K | -150.19K | 329.93K | -305.91K | -256.57K | 343.94K | -253.97K | 85.14K | -339.68K | 145.84K | -665.38K | -3M | -3.7M | -4.72M | -3.6M | -800K |
Capital Expenditures | -5.18K | -584.16K | -864.72K | -44.14K | -84.33K | n/a | -4.84K | -3.69M | -1.69M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -15.01K | -5.28K | -4.01K | -1.77K | -74.99K | -20.31K | -40.49K | -23.11K | -77.43K | -424.52K | -283.84K | -200K | -100K |
Acquisitions | n/a | 958.04K | 3.06M | n/a | -200K | -3.65M | -804.04K | -2.9M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 174.18K | n/a | n/a | n/a | n/a | n/a | n/a | 1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 16.85K | -958.04K | -675 | -44.14 | n/a | 6.42K | -804.04K | -2.9B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 649.81K | -2.87K | -2.87K | -16.58K | -18.94K | -20.9K | -14.28K | -115.73K | n/a | -217.63K | -146.53K | -1.06M | n/a | n/a |
Investing Cash Flow | 11.67K | -584.16K | 2.19M | -44.14K | -284.33K | -3.64M | -808.88K | -6.59M | -1.51M | n/a | n/a | n/a | n/a | n/a | n/a | 1M | -350.19K | -15.01K | -8.14K | -20.59K | -20.71K | -95.89K | -34.59K | -156.22K | -23.11K | -295.05K | -571.05K | -1.35M | -200K | -100K |
Debt Repayment | n/a | n/a | n/a | 1.67M | n/a | -1.98M | n/a | 3.79M | 6.24M | -2K | 20.5K | 8K | 27.45K | n/a | n/a | n/a | 10.00 | -773 | -55.81K | -41.99K | -4.25K | n/a | -225.24K | -14.15K | -520.4K | 341.58K | 381.47K | -202.25K | n/a | n/a |
Common Stock Repurchased | -1.05M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100K | n/a | n/a | n/a | n/a | -1.36M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | -2,089.2B | -2.09B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -1.34M | 958.04K | 3.29M | 3.37M | 560K | -1.66M | 2.09B | 3.38K | n/a | n/a | n/a | n/a | n/a | 40K | n/a | 1.36M | n/a | n/a | n/a | n/a | 10K | n/a | n/a | n/a | 1.96M | 2.59M | n/a | n/a | 5.4M | 700K |
Financial Cash Flow | -1.34M | 18.18M | 24.9M | 5.53K | 560.00 | 2.69M | 7.05M | 8.8M | 6.24M | 48K | 20.5K | 8K | 47.45K | 40K | n/a | -1.36M | 373.34K | -773 | -55.81K | -41.99K | 5.75K | n/a | -224.24K | 456.37K | 1.45M | 2.98M | 3.26M | 4.54M | 5.4M | 700K |
Net Cash Flow | -15.44M | 367.88K | 15.78M | 1.53M | -939.93K | -3.51M | 3.5M | -498.15K | 1.05M | 4.84K | -1.13K | -16.85K | 17.11K | -666 | -65.04K | -515.19K | 353.08K | -321.69K | -320.52K | 281.36K | -268.93K | -10.75K | -598.51K | 445.99K | 757.94K | -313.36K | -1.01M | -1.53M | 1.6M | -200K |
Free Cash Flow | -14.1M | -17.73M | -12.32M | -3.93M | -2.54M | -2.57M | -2.75M | -6.39M | -5.36M | -43.16K | -21.63K | -24.85K | -30.35K | -40.67K | -65.04K | -150.19K | 329.93K | -320.92K | -261.85K | 339.93K | -255.74K | 10.14K | -359.99K | 105.36K | -688.49K | -3.07M | -4.12M | -5.01M | -3.8M | -900K |